Omada Health
OMDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $68,030 | $61,371 | $54,963 | $47,978 |
| % Growth | 10.9% | 11.7% | 14.6% | – |
| Cost of Goods Sold | $22,959 | $21,192 | $23,063 | $16,001 |
| Gross Profit | $45,071 | $40,179 | $31,900 | $31,977 |
| % Margin | 66.3% | 65.5% | 58% | 66.6% |
| R&D Expenses | $10,301 | $10,004 | $8,806 | $9,171 |
| G&A Expenses | $14,340 | $12,308 | $11,320 | $0 |
| SG&A Expenses | $37,283 | $34,519 | $31,490 | $29,905 |
| Sales & Mktg Exp. | $22,943 | $22,318 | $20,170 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $47,584 | $44,523 | $40,296 | $39,076 |
| Operating Income | -$2,513 | -$4,344 | -$8,396 | -$7,099 |
| % Margin | -3.7% | -7.1% | -15.3% | -14.8% |
| Other Income/Exp. Net | -$665 | -$967 | -$1,052 | -$1,150 |
| Pre-Tax Income | -$3,178 | -$5,311 | -$9,448 | -$8,249 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,178 | -$5,311 | -$9,448 | -$8,249 |
| % Margin | -4.7% | -8.7% | -17.2% | -17.2% |
| EPS | -0.055 | -0.093 | -0.17 | -0.15 |
| % Growth | 40.5% | 45.5% | -13.3% | – |
| EPS Diluted | -0.06 | -0.093 | -0.17 | -0.15 |
| Weighted Avg Shares Out | 52,967 | 57,321 | 55,744 | 55,744 |
| Weighted Avg Shares Out Dil | 57,658 | 57,321 | 55,744 | 55,744 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,656 | $863 | $542 | $174 |
| Interest Expense | $0 | $1,094 | $1,074 | $1,097 |
| Depreciation & Amortization | $1,359 | $1,352 | $1,333 | $1,278 |
| EBITDA | -$1,819 | -$2,865 | -$7,041 | -$5,874 |
| % Margin | -2.7% | -4.7% | -12.8% | -12.2% |